Captor Capital Will Resume Trading on the CSE on August 8, 2018 as Shareholders Approve Change of Business to Cannabis
Captor also announced today that John Zorbas has been appointed Chief Executive Officer following Henry Kloepper’s resignation. Mr. Kloepper will continue to work with Captor as a director and Captor extends its appreciation and gratitude to Mr. Kloepper for his work as CEO and looks forward to continuing to work with him.
At the Meeting, shareholders re-elected John Zorbas, Henry Kloepper, Kyle Appleby and Alex Dementev as directors of Captor. MNP, LLP were re-appointed as auditors for Captor and shareholders ratified and confirmed Captor’s 10% rolling stock option plan.
Captor’s audited annual financial statements and MD&A for the year ended March 31, 2018 have been released and they can be found at Captor’s profile on www.sedar.com
About Captor Capital
Captor Capital Corp. is a Canadian investment firm focused on the cannabis sector listed on the Canadian Securities Exchange, the OTC, and the Frankfurt Stock Exchange. The company follows a strategy of acquiring cash flowing established companies and organizations with growth potential that require capital to scale. Captor currently has a number of revenue generating cannabis investments including two wholly owned branded MedMen dispensaries – the world famous West Hollywood location that was featured on Jimmy Kimmel Live and the and the showpiece Orange County dispensary in Santa Ana. Captor Capital is currently looking at additional revenue generating investments in the cannabis space and will be updating the market in due course.
For further information, please contact
Gavin Davidson
Captor Capital Corp.
705.446.6630
gavin@captorcapital.com
Forward-Looking Statements
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This press release contains or refers to forward-looking information, and is based on current expectations that involve a number of business risks and uncertainties. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to availability of investment opportunities, economic circumstances, market fluctuations and uncertainties, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, and the other risks involved in the investment industry and junior capital markets. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. Readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law.